New cancer clinical trial: Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Published on: February 01, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share